Rodan + Fields:registered: Dermatologists is changing skin and changing lives by partnering with independent business owners across the United States to redefine the future of aging. Founded by world-renowned dermatologists Dr. Katie Rodan and Dr. Kathy Fields, the creators of Proactiv:registered: Solution, Rodan + Fields' patent-pending MACRO Exfoliator:tm: and AMP MD:tm: System make real results possible at home without injections or other invasive procedures. Named the 2010 Rising Star by the Direct Selling Association (DSA) for its dedication to achieving a high standard of excellence in business operations, and awarded numerous awards for business campaigns and products, Rodan + Fields is the anti-aging company to watch. Dr. Katie Rodan and Dr. Kathy Fields founded Rodan + Fields:registered: Dermatologists in 2002 to extend their vision of bringing dermatology-based skin treatment to everyone. Originally available as a top-selling clinical skincare brand in high-end department stores, the company realized the Doctors’ vision could never be fully realized when confined to the department store counter. In an unprecedented move, Rodan + Fields became the first prestige skincare line to exit the department store for the world of direct selling. And today, there are numerous Rodan + Fields independent business owners experiencing the income associated with sales volume that far exceeds what leading department store chains were able to achieve. The power of the individual, combined with Rodan + Fields’ brand legacy, clinically proven products and a proprietary systematic approach to independent business management, makes Rodan + Fields an opportunity like no other.
Some data provided by Crunchbase
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Rodan & Fields LLC or any companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.
To learn more about whether you're eligible, typical investment size, company valuation, and share price, request access here.